The Prognostic Role of Glasgow Prognostic Score and C-reactive Protein to Albumin Ratio for Sarcoma: A System Review and Meta-Analysis

Backgrounds. Both pretreatment serum CRP (C-reactive protein) level and ALB (albumin) level have been found to be predictive of survival for multiple malignancies including sarcoma. Since both of the GPS (Glasgow prognostic score) and CAR (C-reactive protein to albumin ratio) are based on the combin...

Full description

Bibliographic Details
Main Authors: Erhu Fang, Xiaolin Wang, Jiexiong Feng, Xiang Zhao
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:Disease Markers
Online Access:http://dx.doi.org/10.1155/2020/8736509
id doaj-1fe6e4441ed4413d8536d72e478b6c5a
record_format Article
spelling doaj-1fe6e4441ed4413d8536d72e478b6c5a2020-11-25T01:44:36ZengHindawi LimitedDisease Markers0278-02401875-86302020-01-01202010.1155/2020/87365098736509The Prognostic Role of Glasgow Prognostic Score and C-reactive Protein to Albumin Ratio for Sarcoma: A System Review and Meta-AnalysisErhu Fang0Xiaolin Wang1Jiexiong Feng2Xiang Zhao3Department of Pediatric Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, ChinaDepartment of Pediatric Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, ChinaDepartment of Pediatric Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, ChinaDepartment of Pediatric Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, ChinaBackgrounds. Both pretreatment serum CRP (C-reactive protein) level and ALB (albumin) level have been found to be predictive of survival for multiple malignancies including sarcoma. Since both of the GPS (Glasgow prognostic score) and CAR (C-reactive protein to albumin ratio) are based on the combination of CRP and ALB, we conducted a meta-analysis to evaluate the prognostic role of these two parameters for sarcoma patients. Methods. A detailed literature search was conducted in MEDLINE, Embase, and Cochrane Library for relevant research publications written in English. Patients’ clinical characteristics, outcomes of overall survival (OS), disease-specific survival (DSS), and disease-free survival (DFS) were extracted. Pooled hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) were combined to evaluate the prognostic role of GPS or CAR. Results. Twelve articles containing 2695 patients were identified as eligible studies. The results showed that an elevated GPS was significantly correlated with poor OS (HR=2.42; 95% CI: 1.98-2.94; p<0.001; fixed-effects model), DSS (HR=2.28; 95% CI: 1.75-2.97; p<0.001; fixed-effects model), and DFS (HR=2.05; 95% CI: 1.62-2.60; p<0.001; fixed-effects model). A higher CAR also was shown to be significantly correlated with poor OS (HR=2.23; 95% CI: 1.70-2.92; p<0.001; fixed-effects model) and DFS (HR=1.81; 95% CI: 1.7-2.58; p=0.001; fixed-effects model). Conclusion. An elevated GPS is predictive of poor survival in patients with sarcomas and is promising to be used as a factor for risk stratification. A higher CAR value is also predictive of poor survival; however, the optimal CAR cut-off value is still to be determined.http://dx.doi.org/10.1155/2020/8736509
collection DOAJ
language English
format Article
sources DOAJ
author Erhu Fang
Xiaolin Wang
Jiexiong Feng
Xiang Zhao
spellingShingle Erhu Fang
Xiaolin Wang
Jiexiong Feng
Xiang Zhao
The Prognostic Role of Glasgow Prognostic Score and C-reactive Protein to Albumin Ratio for Sarcoma: A System Review and Meta-Analysis
Disease Markers
author_facet Erhu Fang
Xiaolin Wang
Jiexiong Feng
Xiang Zhao
author_sort Erhu Fang
title The Prognostic Role of Glasgow Prognostic Score and C-reactive Protein to Albumin Ratio for Sarcoma: A System Review and Meta-Analysis
title_short The Prognostic Role of Glasgow Prognostic Score and C-reactive Protein to Albumin Ratio for Sarcoma: A System Review and Meta-Analysis
title_full The Prognostic Role of Glasgow Prognostic Score and C-reactive Protein to Albumin Ratio for Sarcoma: A System Review and Meta-Analysis
title_fullStr The Prognostic Role of Glasgow Prognostic Score and C-reactive Protein to Albumin Ratio for Sarcoma: A System Review and Meta-Analysis
title_full_unstemmed The Prognostic Role of Glasgow Prognostic Score and C-reactive Protein to Albumin Ratio for Sarcoma: A System Review and Meta-Analysis
title_sort prognostic role of glasgow prognostic score and c-reactive protein to albumin ratio for sarcoma: a system review and meta-analysis
publisher Hindawi Limited
series Disease Markers
issn 0278-0240
1875-8630
publishDate 2020-01-01
description Backgrounds. Both pretreatment serum CRP (C-reactive protein) level and ALB (albumin) level have been found to be predictive of survival for multiple malignancies including sarcoma. Since both of the GPS (Glasgow prognostic score) and CAR (C-reactive protein to albumin ratio) are based on the combination of CRP and ALB, we conducted a meta-analysis to evaluate the prognostic role of these two parameters for sarcoma patients. Methods. A detailed literature search was conducted in MEDLINE, Embase, and Cochrane Library for relevant research publications written in English. Patients’ clinical characteristics, outcomes of overall survival (OS), disease-specific survival (DSS), and disease-free survival (DFS) were extracted. Pooled hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) were combined to evaluate the prognostic role of GPS or CAR. Results. Twelve articles containing 2695 patients were identified as eligible studies. The results showed that an elevated GPS was significantly correlated with poor OS (HR=2.42; 95% CI: 1.98-2.94; p<0.001; fixed-effects model), DSS (HR=2.28; 95% CI: 1.75-2.97; p<0.001; fixed-effects model), and DFS (HR=2.05; 95% CI: 1.62-2.60; p<0.001; fixed-effects model). A higher CAR also was shown to be significantly correlated with poor OS (HR=2.23; 95% CI: 1.70-2.92; p<0.001; fixed-effects model) and DFS (HR=1.81; 95% CI: 1.7-2.58; p=0.001; fixed-effects model). Conclusion. An elevated GPS is predictive of poor survival in patients with sarcomas and is promising to be used as a factor for risk stratification. A higher CAR value is also predictive of poor survival; however, the optimal CAR cut-off value is still to be determined.
url http://dx.doi.org/10.1155/2020/8736509
work_keys_str_mv AT erhufang theprognosticroleofglasgowprognosticscoreandcreactiveproteintoalbuminratioforsarcomaasystemreviewandmetaanalysis
AT xiaolinwang theprognosticroleofglasgowprognosticscoreandcreactiveproteintoalbuminratioforsarcomaasystemreviewandmetaanalysis
AT jiexiongfeng theprognosticroleofglasgowprognosticscoreandcreactiveproteintoalbuminratioforsarcomaasystemreviewandmetaanalysis
AT xiangzhao theprognosticroleofglasgowprognosticscoreandcreactiveproteintoalbuminratioforsarcomaasystemreviewandmetaanalysis
AT erhufang prognosticroleofglasgowprognosticscoreandcreactiveproteintoalbuminratioforsarcomaasystemreviewandmetaanalysis
AT xiaolinwang prognosticroleofglasgowprognosticscoreandcreactiveproteintoalbuminratioforsarcomaasystemreviewandmetaanalysis
AT jiexiongfeng prognosticroleofglasgowprognosticscoreandcreactiveproteintoalbuminratioforsarcomaasystemreviewandmetaanalysis
AT xiangzhao prognosticroleofglasgowprognosticscoreandcreactiveproteintoalbuminratioforsarcomaasystemreviewandmetaanalysis
_version_ 1715678360413143040